428 related articles for article (PubMed ID: 27633508)
1. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.
Fraguas-Sánchez AI; Fernández-Carballido A; Torres-Suárez AI
Expert Opin Investig Drugs; 2016 Nov; 25(11):1311-1323. PubMed ID: 27633508
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids as Anticancer Drugs.
Ramer R; Hinz B
Adv Pharmacol; 2017; 80():397-436. PubMed ID: 28826542
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system and cancer: therapeutic implication.
Guindon J; Hohmann AG
Br J Pharmacol; 2011 Aug; 163(7):1447-63. PubMed ID: 21410463
[TBL] [Abstract][Full Text] [Related]
5. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
McAllister SD; Soroceanu L; Desprez PY
J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids and Cancer.
Velasco G; Sánchez C; Guzmán M
Handb Exp Pharmacol; 2015; 231():449-72. PubMed ID: 26408171
[TBL] [Abstract][Full Text] [Related]
7. Antitumorigenic targets of cannabinoids - current status and implications.
Ramer R; Hinz B
Expert Opin Ther Targets; 2016 Oct; 20(10):1219-35. PubMed ID: 27070944
[TBL] [Abstract][Full Text] [Related]
8. Targeting the endocannabinoid system for the treatment of cancer--a practical view.
Fowler CJ; Gustafsson SB; Chung SC; Persson E; Jacobsson SO; Bergh A
Curr Top Med Chem; 2010; 10(8):814-27. PubMed ID: 20370711
[TBL] [Abstract][Full Text] [Related]
9. Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.
Pisanti S; Malfitano AM; Grimaldi C; Santoro A; Gazzerro P; Laezza C; Bifulco M
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):117-31. PubMed ID: 19285265
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour actions of cannabinoids.
Hinz B; Ramer R
Br J Pharmacol; 2019 May; 176(10):1384-1394. PubMed ID: 30019449
[TBL] [Abstract][Full Text] [Related]
11. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor systems: therapeutic targets for tumour intervention.
Jones S; Howl J
Expert Opin Ther Targets; 2003 Dec; 7(6):749-58. PubMed ID: 14640910
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids, endocannabinoids, and cancer.
Hermanson DJ; Marnett LJ
Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
Oesch S; Gertsch J
J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids - a new weapon against cancer?
Pokrywka M; Góralska J; Solnica B
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1309-1320. PubMed ID: 28100841
[TBL] [Abstract][Full Text] [Related]
16. The use of cannabinoids as anticancer agents.
Velasco G; Hernández-Tiedra S; Dávila D; Lorente M
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():259-66. PubMed ID: 26071989
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol as potential anticancer drug.
Massi P; Solinas M; Cinquina V; Parolaro D
Br J Clin Pharmacol; 2013 Feb; 75(2):303-12. PubMed ID: 22506672
[TBL] [Abstract][Full Text] [Related]
18. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids and cancer: pros and cons of an antitumour strategy.
Bifulco M; Laezza C; Pisanti S; Gazzerro P
Br J Pharmacol; 2006 May; 148(2):123-35. PubMed ID: 16501583
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review).
Bifulco M; Laezza C; Gazzerro P; Pentimalli F
Oncol Rep; 2007 Apr; 17(4):813-6. PubMed ID: 17342320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]